Clinical data, regulatory milestones, AI-assisted discovery platforms, and expanding development pipelines are creating a steady stream of catalysts that investors will be watching closely during the ...

(NASDAQ:IRD), backed by significant analyst-implied upside, ranks among the overlooked penny stocks to buy right now. A ...

Biohaven Ltd. BHVN shares fell Monday after Bank of America Securities (BofA) downgraded the biotechnology company, citing an ...

BTIG raised its price target on Abivax to $175 from $150 and maintained a Buy rating. ・Wedbush said that it remains concerned about how the FDA will view cancer risk and the potential for a Black Box ...

Research Capital analyst Andre Uddin says Medicenna Therapeutics (Medicenna Therapeutics Stock Quote, Chart, News, Analysts, ...

TheFly reported on June 24 that Cantor Fitzgerald analyst Prakhar Agrawal initiated coverage of SLN with an Overweight rating ...

That would be an impressive run if it could get there soon.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The FDA first awarded a regenerative medicine advanced therapeutic (RMAT) designation in 2017. Credit: Tada Images / Shutterstock.com Since the first time the US Food and Drug Administration (FDA) ...